KRONOS BIO INC. - COM
0.8700
08-十月-24 10:33:31
15 分钟延时
股票
-0.1200
-12.12%
今日范围
0.8700 - 0.9800
ISIN
N/A
来源
NASDAQ
-
02 11月 2023 16:05:00 条件 Nasdaq GlobeNewswire
-
27 10月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
13 10月 2023 12:30:00 条件 Nasdaq GlobeNewswire
-
04 10月 2023 16:05:00 条件 Nasdaq GlobeNewswire
-
Kronos Bio Announces Departure of Chief Financial Officer and Head of Corporate Development
17 8月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
Kronos Bio Reports Recent Business Progress and Second-Quarter 2023 Financial Results
08 8月 2023 16:05:03 条件 Nasdaq GlobeNewswire
-
06 6月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
Kronos Bio Announces Participation in Upcoming Investor Conferences
01 6月 2023 16:05:00 条件 Nasdaq GlobeNewswire
-
Kronos Bio Reports Recent Business Progress and First-Quarter 2023 Financial Results
10 5月 2023 16:05:02 条件 Nasdaq GlobeNewswire
-
Kronos Bio Appoints Roger Dansey, M.D., to Board of Directors
24 4月 2023 16:05:00 条件 Nasdaq GlobeNewswire
-
Kronos Bio Announces Changes to Board of Directors
11 4月 2023 16:05:00 条件 Nasdaq GlobeNewswire
-
Kronos Bio Reports Recent Business Progress and Fourth-Quarter and Full-Year 2022 Financial Results
15 3月 2023 16:05:00 条件 Nasdaq GlobeNewswire
-
Kronos Bio Announces Participation in 43rd Annual Cowen Health Care Conference
28 2月 2023 16:05:00 条件 Nasdaq GlobeNewswire
-
09 1月 2023 07:00:04 条件 Nasdaq GlobeNewswire
-
Kronos Bio Announces Participation in Upcoming Investor Conferences
22 11月 2022 16:05:00 条件 Nasdaq GlobeNewswire
-
Kronos Bio Reports Recent Business Progress and Third-Quarter 2022 Financial Results
08 11月 2022 16:10:00 条件 Nasdaq GlobeNewswire
-
Kronos Bio Announces Prioritization of Clinical Portfolio to Focus on Lanraplenib and KB-0742
08 11月 2022 16:05:02 条件 Nasdaq GlobeNewswire